Terms: = Head and neck cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Diagnosis
194 results:
1. Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies.
Ruby L; Jayaprakasam VS; Fernandes MC; Paroder V
Hematol Oncol Clin North Am; 2024 Jun; 38(3):711-730. PubMed ID: 38575457
[TBL] [Abstract] [Full Text] [Related]
2. Oncocytoid Salivary Tumors: Differential diagnosis and Utility of Newly Described Immunohistochemistry.
Katabi N
Head Neck Pathol; 2024 Mar; 18(1):20. PubMed ID: 38502259
[TBL] [Abstract] [Full Text] [Related]
3. Salivary gland carcinoma: Towards a more personalised approach.
Rached L; Saleh K; Casiraghi O; Even C
Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
[TBL] [Abstract] [Full Text] [Related]
4. Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus.
Porschen R; Fischbach W; Gockel I; Hollerbach S; Hölscher A; Jansen PL; Miehlke S; Pech O; Stahl M; Vanhoefer U; Ebert MPA
United European Gastroenterol J; 2024 Apr; 12(3):399-411. PubMed ID: 38284661
[TBL] [Abstract] [Full Text] [Related]
5. Thyroid Ultrasound Image Database and Marker Mask Inpainting Method for Research and Development.
Li X; Fu C; Xu S; Sham CW
Ultrasound Med Biol; 2024 Apr; 50(4):509-519. PubMed ID: 38267314
[TBL] [Abstract] [Full Text] [Related]
6. her2 low expression breast cancer subtyping and their correlation with prognosis and immune landscape based on the histone modification related genes.
Li J; Yao J; Qi L
Sci Rep; 2023 Dec; 13(1):21753. PubMed ID: 38066224
[TBL] [Abstract] [Full Text] [Related]
7. Unveiling Therapeutic Targets for Esophageal cancer: A Comprehensive Review.
Acharya R; Mahapatra A; Verma HK; Bhaskar LVKS
Curr Oncol; 2023 Oct; 30(11):9542-9568. PubMed ID: 37999111
[TBL] [Abstract] [Full Text] [Related]
8. Current and Emerging Role of Monoclonal Antibody-Based First-Line Treatment in Advanced Gastro-Esophageal and Gastric cancer.
Désilets A; Elkhoury R; Gebai A; Tehfe M
Curr Oncol; 2023 Oct; 30(10):9304-9316. PubMed ID: 37887572
[TBL] [Abstract] [Full Text] [Related]
9. What Therapeutic Biomarkers in Gastro-Esophageal Junction and Gastric cancer Should a Pathologist Know About?
Kumarasinghe MP; Houghton D; Allanson BM; Price TJ
Surg Pathol Clin; 2023 Dec; 16(4):659-672. PubMed ID: 37863558
[TBL] [Abstract] [Full Text] [Related]
10. Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNIcancer, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR).
Veziant J; Bouché O; Aparicio T; Barret M; El Hajbi F; Lepilliez V; Lesueur P; Maingon P; Pannier D; Quero L; Raoul JL; Renaud F; Seitz JF; Serre AA; Vaillant E; Vermersch M; Voron T; Tougeron D; Piessen G; ; ; ; ; ; ; ; ; ;
Dig Liver Dis; 2023 Dec; 55(12):1583-1601. PubMed ID: 37635055
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and Meta-Analysis.
Key S; Chia C; Hasan Z; Sundaresan P; Riffat F; Dwivedi RC
Laryngoscope; 2024 Mar; 134(3):1042-1053. PubMed ID: 37610148
[TBL] [Abstract] [Full Text] [Related]
12. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
13. Changes in cancer mortality after Medicaid expansion and the role of stage at diagnosis.
Barnes JM; Johnson KJ; Osazuwa-Peters N; Yabroff KR; Chino F
J Natl Cancer Inst; 2023 Aug; 115(8):962-970. PubMed ID: 37202350
[TBL] [Abstract] [Full Text] [Related]
14. Analyses of single extracellular vesicles from non-small lung cancer cells to reveal effects of epidermal growth factor receptor inhibitor treatments.
Stridfeldt F; Cavallaro S; Hååg P; Lewensohn R; Linnros J; Viktorsson K; Dev A
Talanta; 2023 Jul; 259():124553. PubMed ID: 37084607
[TBL] [Abstract] [Full Text] [Related]
15. Explore the diagnostic performance of 2020 Chinese Thyroid Imaging Reporting and Data Systems by comparing with the 2017 ACR-TIRADS guidelines: a single-center study.
Cai M; Chen L; Shui L; Lv X; Wang H
Endocrine; 2023 May; 80(2):399-407. PubMed ID: 36930437
[TBL] [Abstract] [Full Text] [Related]
16. Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal cancers in the United States.
Mehta R; Liepa AM; Zheng S; Chatterjee A
Curr Oncol; 2023 Feb; 30(2):1869-1881. PubMed ID: 36826106
[TBL] [Abstract] [Full Text] [Related]
17. Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatment.
Xiao H; Bertwistle D; Khela K; Middleton-Dalby C; Hall J
BMC Cancer; 2023 Feb; 23(1):186. PubMed ID: 36823552
[TBL] [Abstract] [Full Text] [Related]
18. Predicting the her2 status in oesophageal cancer from tissue microarrays using convolutional neural networks.
Pisula JI; Datta RR; Valdez LB; Avemarg JR; Jung JO; Plum P; Löser H; Lohneis P; Meuschke M; Dos Santos DP; Gebauer F; Quaas A; Walch A; Bruns CJ; Lawonn K; Popp FC; Bozek K
Br J Cancer; 2023 Mar; 128(7):1369-1376. PubMed ID: 36717673
[TBL] [Abstract] [Full Text] [Related]
19. Bioinformatics analysis of miRNA and its associated genes to identify potential biomarkers of oral submucous fibrosis and oral malignancy.
Mohanan EM; Jhala D; More CB; Patel AK; Joshi C
Cancer Rep (Hoboken); 2023 Apr; 6(4):e1787. PubMed ID: 36708238
[TBL] [Abstract] [Full Text] [Related]
20. Primary salivary duct carcinoma of the lung: clinicopathological features, diagnosis and practical challenges.
Li S; Hou L; Huang Y; Wu W; Wu C; Zhang L
J Clin Pathol; 2024 Apr; 77(5):324-329. PubMed ID: 36697219
[TBL] [Abstract] [Full Text] [Related]
[Next]
